sickle cell disease
Sickle Cell Drug Oxbryta Withdrawn From Market
Pfizer is voluntarily withdrawing its SCD medication Oxbryta from the market due to safety concerns.
SEPTEMBER 27, 2024
Who Will Pay for Sickle Cell Gene Therapy?
The December 2023 FDA approval of the first two gene therapies to treat sickle cell disease was a giant step ...
FEBRUARY 26, 2024
FDA Approves First Gene Therapies to Treat Patients With Sickle Cell Disease
The FDA approved the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients ...
DECEMBER 8, 2023
Options Growing for Managing Sickle Cell Disease
Sickle cell disease causes significant pain and other complications among approximately 100,000 U.S. residents and ...
OCTOBER 8, 2023
FDA Lowers Age Indication for Oxbryta to Treat Younger Children With Sickle Cell Disease
One out of every 365 births of Black children and one out of every 16,300 Hispanic births results in a child with ...
DECEMBER 21, 2021
New SCD Pain Recs Call For Individualized Care
People living with chronic pain due to sickle cell disease (SCD) should be managed with a variety of pharmacologic ...
OCTOBER 20, 2020
FDA Approves Novel Treatment for Abnormality in Sickle Cell Disease
Oxbryta inhibits deoxygenated sickle hemoglobin polymerization, which is the central abnormality in sickle cell ...
NOVEMBER 26, 2019
FDA Approves Adakveo for Painful Complication of Sickle Cell Disease
The FDA approved crizanlizumab-tmca for sickle cell patients 16 and older who suffer vaso-occlusive crisis, a ...
NOVEMBER 18, 2019
FDA Approves Endari for Sickle Cell Disease
Endari is first new sickle cell drug in 20 years and first one approved for pediatric patients.
JULY 10, 2017
Thrombolytic Therapy Safe in Sickle Cell Disease Patients
Tissue plasminogen activator is as safe in treating ischemic stroke in patients who have sickle cell disease as it ...
MAY 18, 2017
Experimental Antibody Reduces Sickle Cell–Related Pain Crises
Sickle cell disease is characterized by recurrent episodes of “sickle crisis,” in which a ...
FEBRUARY 6, 2017
